Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Minnesota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Minnesota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Minnesota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David King (NPI 1417049396)

Field	Value
Entity Type	Individual
Organization	David King
Address	480 Osborne Rd Ne
City	Fridley
State	MN
ZIP	55432
Taxonomy	Medical Oncology Physician
NPI Enumerated	September 29, 2006

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

DAVID KING is a Medical Oncology Physician in FRIDLEY, MN with Medicare lifetime revenue of $1.3M and no Medicaid billing on file, indicating this profile is effectively single‑payer Medicare. The NPI was enumerated 2006-09-29 (~20 years ago), which suggests an established practice footprint rather than a newly entered clinician.

Revenue is highly concentrated in high-cost oncology injections: the precomputed top three Medicare codes account for 79.3% of this provider's Medicare revenue. Specifically, J9271 (13.8K claims, $43 avg paid/claim, $593.4K revenue, 46.7%) and J9299 (12.3K claims, $24 avg paid/claim, $294.2K revenue, 23.1%) together dominate the revenue mix, with J0897 (6.4K claims, $19 avg paid/claim, $120.8K revenue, 9.5%) the third-largest contributor.

The code-level competitive standing shows this provider is a modest national participant for the largest drug codes rather than a dominant outlier: J9271 ranks #771 of 1841 (57th percentile) and J9299 ranks #301 of 505 (40th percentile), both labeled as typical, unremarkable volume for their respective peer sets. J0897 is more active relative to its broader peer base (rank #2129 of 10057, 79th percentile) but still characterized as typical volume, so the practice appears within normal national ranges for oncology infusion providers.

Clinical service mix includes meaningfully above-typical office evaluation and management activity: 99214 (716 claims, $97 avg paid/claim, $69.5K revenue, 5.5%) ranks #24999 of 479517 (95th percentile) and is explicitly noted as "notably above typical national volume." The elevated 99214 percentile alongside chemotherapy codes suggests regular longitudinal management of established oncology patients in clinic rather than isolated drug-only encounters.

Ancillary infusion and lab services support an on-site treatment workflow: chemotherapy administration 96413 (340 claims, $105 avg paid/claim, $35.7K revenue, 2.8%) and add-on/administration codes such as 96417 and 96365 appear on the roster, and lab panels like 80053 (1K claims, $10 avg paid/claim, $10.2K revenue, 0.8%) and 85025 (1.2K claims, $8 avg paid/claim, $9.6K revenue, 0.8%) are present at high peer percentiles (95th and 94th respectively). This pattern is consistent with an infusion practice that performs both therapeutic administrations and routine monitoring.

The payer mix is sharply skewed: Medicare accounts for all recorded public-payer revenue ($1.3M) while Medicaid shows none (no Medicaid billing on file), concentrating reimbursement exposure to Medicare policies and pricing. That concentration reduces Medicaid-related administrative complexity but increases sensitivity to Medicare reimbursement changes for high-cost oncology drugs.

From a business-risk and opportunity perspective, the practice's dependence on a small number of high-revenue biologic agents (J9271, J9299, J0897) means revenue is sensitive to changes in utilization, unit price, or prior authorization rules for those agents. At the same time, the combination of above-typical E/M volume and integrated lab/administration services indicates a stable clinical relationship with patients that could support care-pathway value initiatives or alternative payment arrangements if pursued.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

55 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	13,800	$40	$593.4K
J9299	Injection, nivolumab, 1 mg	12,260	$20	$294.2K
J0897	Injection, denosumab, 1 mg	6,360	$20	$120.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	720	$100	$69.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	340	$110	$35.7K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	16,200	$1	$32.4K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	180	$130	$23.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	330	$60	$21.2K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	1,020	$10	$10.2K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	1,200	$10	$9.6K

Showing 1–10 of 55

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 55 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Minnesota Distribution

David King — 9 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Minnesota

Full comparison — all codes billed, vs. state median

55 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	3	70	7,200	$40	$323.3K
J9299	2	20	5,240	$20	$159.4K
J0897	9	90	1,770	$20	$50.8K
J0881	2	20	10,680	$1	$25.4K
J9217	15	80	80	$130	$17.1K
J0185	23	30	7,800	$1	$11.9K
96413	15	230	70	$100	$11.5K
99214	40	10,100	70	$80	$8.1K
Q0138	3	20	14,790	$1	$6.3K
99232	2,704	3,640	60	$60	$5.2K

Showing 1–10 of 55

Related Providers

Other providers that share a Tax Identification Number (TIN) with David King, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Holland Center	MN	Developmentally Disabled Services Day Training Agency	$0	$16.3M
Minnesota Oncology Hematology, PA	MN	Hematology & Oncology Physician	$0	$8.1M
Robert Delaune	MN	Hematology & Oncology Physician	$1.9M	$0
Vladimir Hugec	MN	Hematology & Oncology Physician	$1.8M	$0
Yang Liu	MN	Hematology & Oncology Physician	$1.4M	$0
Avina Singh	MN	Hematology & Oncology Physician	$971.9K	$0
Ben Zhang	MN	Hematology & Oncology Physician	$914.4K	$0
Uzma Ali	MN	Hematology & Oncology Physician	$868.9K	$0
Samith Thomas Kochuparambil	MN	Hematology & Oncology Physician	$827.8K	$0
Ryan Funk	MN	Radiation Oncology Physician	$716.7K	$0

Nearby Providers

Other providers in the same ZIP code as David King, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Lee Carlson Center For Mental Health And Well-being	MN	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$9.4M
Minimed Distribution Corp	MN	Durable Medical Equipment & Medical Supplies	$0	$7.7M
Allina Health System	MN	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$7.3M
Kci Usa, Inc.	MN	Durable Medical Equipment & Medical Supplies	$0	$6.5M
Transformation House, Inc.	MN	Substance Abuse Rehabilitation Facility	$0	$5.9M
Swana Dental Delivery	MN	Dental Clinic/Center	$0	$5.1M
Total Medical Supply Co Inc	MN	Durable Medical Equipment & Medical Supplies	$0	$4.6M
Fridley Public Schools	MN	Local Education Agency (LEA)	$0	$4.6M
Andrew Cozadd	MN	Physician Assistant	$874.6K	$0
Jenna Borkenhagen	MN	Radiation Oncology Physician	$491.7K	$0

David King — Billing Profile & Reimbursement Data

Sign up for David King — Billing Profile & Reimbursement Data policy alerts

David King — Billing Profile & Reimbursement Data

Sign up for David King — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References